Wells Fargo Downgrades Amgen (AMGN) to Equal Weight

August 7, 2024 3:33 AM EDT Send to a Friend
Wells Fargo analyst Mohit Bansal downgraded Amgen (NASDAQ: AMGN) from Overweight to Equal Weight with a price target of $335.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login